Drug sensitivity studies during a highland malaria epidemic in Kenya.
Khan
B
B
Biomedical Sciences Research Centre, Kenya Medical Research Institute, Nairobi.
Ofulla
A V
AV
Kariuki
D M
DM
Githure
J I
JI
Kabiru
E W
EW
Martin
S K
SK
D000328:Adult; D000655:Amodiaquine / Q000627:therapeutic use; D000818:Animals; D000962:Antimalarials / Q000627:therapeutic use*; D002738:Chloroquine / Q000627:therapeutic use; D004196:Disease Outbreaks; D004338:Drug Combinations; D006801:Humans; D007630:Kenya / Q000453:epidemiology; D016778:Malaria, Falciparum / Q000188:drug therapy* / Q000453:epidemiology; D010963:Plasmodium falciparum / Q000187:drug effects; D011739:Pyrimethamine / Q000627:therapeutic use; D013413:Sulfadoxine / Q000627:therapeutic use; D013415:Sulfalene / Q000627:therapeutic use; D016896:Treatment Outcome
D000962:Antimalarials; D004338:Drug Combinations; D000655:Amodiaquine; D013413:Sulfadoxine; D002738:Chloroquine; D013415:Sulfalene; D011739:Pyrimethamine